Views of American oncologists about the purposes of clinical trials

Journal of the National Cancer Institute

Volumn 94, Issue 24, 2002, Pages 1847-1853

  Joffe, Steven ^a   Weeks, Jane C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RESEARCH; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL ETHICS; MEDICAL SPECIALIST; MULTIVARIATE ANALYSIS; ONCOLOGY; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0037132709     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.24.1847     Document Type: Article

References (40)

1. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. In: Sugarman J, Mastroianni AC, Kahn JP, editors. Ethics of research with human subjects. Frederick (MD): University Publishing Group, Inc.; 1998. p. 19-30.
2. Simes RJ. Risk-benefit relationships in cancer clinical trials: the ECOG experience in non-small-cell lung cancer. J Clin Oncol 1985;3:462-72.
3. Research ethics and the medical profession. Report of the Advisory Committee on Human Radiation Experiments. JAMA 1996;276:403-9.
4. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. JAMA 1998;280:1449-54.
5. Berg JW, Appelbaum PS, Lidz CW, Parker LS. Informed consent: legal theory and clinical practice. 2nd ed. Oxford (U.K.): Oxford University Press; 2001.
6. Katz J. Human experimentation and human rights. Saint Louis Univ Law J 1993;38:7-54.
7. Horng S, Miller FG. Is placebo surgery unethical? N Engl J Med 2002; 347:137-9.
8. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-11.
9. Fried C. Medical experimentation: personal integrity and social policy. New York (NY): American Elsevier; 1974.
10. Levine RJ. Ethics and regulation of clinical research. 2nd ed. Baltimore (MD): Urban & Schwarzenberg; 1986.
11. National Bioethics Advisory Commission. Ethical and policy issues in international research: clinical trials in developing countries. Bethesda (MD): National Bioethics Advisory Commission; 2001. p. 48.
12. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: informed consent in psychiatric research. Int J Law Psychiatry 1982;5:319-29.
13. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987;17:20-4.
14. Benson PR, Roth LH, Appelbaum PS, Lidz CW, Winslade WJ. Information disclosure, subject understanding, and informed consent in psychiatric research. Law Hum Behav 1988;12:455-75.
15. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001;358: 1772-7.
16. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst 2001;93:139-47.
17. Veatch RM. The patient as partner: a theory of human-experimentation ethics. Bloomington (IN): Indiana University Press; 1987.
18. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043-5.
19. Tejeda HA, Green SB, Trimble EL, Ford L, High JL, Ungerleider RS, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996;88:812-6.
20. Bleyer WA. The U.S. pediatric cancer clinical trials programmes: international implications and the way forward. Eur J Cancer 1997;33:1439-47.
21. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7.
22. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344: 1052-6.
23. Canellos GP. Clinical research saves money: reflections on high-dose therapy of breast cancer. J Clin Oncol 1999;17:1965-6.
24. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med 2000;342:1069-76.
25. Mello MM, Brennan TA. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Aff (Millwood) 2001;20:101-17.
26. Welch HG, Mogielnicki J. Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer. BMJ 2002;324: 1088-92.
27. Advisory Committee on Human Radiation Experiments. Final Report. New York (NY): Oxford University Press; 1996.
28. Simon C, Eder M, Raiz P, Zyzanski S, Pentz R, Kodish ED. Informed consent for pediatric leukemia research: clinician perspectives. Cancer 2001;92:691-700.
29. Lantos JD. The "inclusion benefit" in clinical trials. J Pediatr 1999;134: 130-1.
30. Taylor KM, Kelner M. Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile. J Health Soc Behav 1987; 28:389-400.
31. Taylor KM. Integrating conflicting professional roles: physician participation in randomized clinical trials. Soc Sci Med 1992;35:217-24.
32. Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol 1994;12:1796-805.
33. Bailes J. Managed care and oncology: the quality debate. J Clin Oncol 2000;18:705-7.
34. Access to quality cancer care: consensus statement. American Federation of Clinical Oncology Societies. J Clin Oncol 1998;16:1628-30.
35. Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep 2000;30:34-43.
36. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994;331: 1136-42.
37. Ayanian JZ, Landrum MB, Normand SL, Guadagnoli E, McNeil BJ. Rating the appropriateness of coronary angiography - do practicing physicians agree with an expert panel and with each other? N Engl J Med 1998;338: 1896-904.
38. Emanuel EJ, Fairclough D, Clarridge BC, Blum D, Bruera E, Penley WC, et al. Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide. Ann Intern Med 2000;133:527-32.
39. Mangus RS, Dipiero A, Hawkins CE. Medical students' attitudes toward physician-assisted suicide. JAMA 1999;282:2080-1.
40. Back AL, Wallace JI, Starks HE, Pearlman RA. Physician-assisted suicide and euthanasia in Washington State. Patient requests and physician responses. JAMA 1996;275:919-25.